Aevice Health vs Truvian Health
Side-by-side comparison of AI visibility scores, market position, and capabilities
Aevice Health raised $30M Series B in 2025 for its AI-powered wearable respiratory monitor that continuously tracks wheezing, coughing, and breathing abnormalities in asthma and COPD patients.
About
Aevice Health develops wearable respiratory monitoring technology that uses AI to analyze breath sounds captured continuously from a chest-worn device. The AeviceMD system detects wheezing, coughing, and abnormal breathing patterns in real time, enabling early warning of asthma attacks and COPD exacerbations before they require emergency care. The device transmits data to a smartphone app and clinical dashboard for remote monitoring by pulmonologists.
Truvian Health received FDA 510(k) clearance for its TruVerus benchtop blood analyzer in Dec 2025; raised $74M in July 2024 and is partnering with Shoppers Drug Mart for commercial rollout.
About
Truvian Health is a San Diego-based medical diagnostics company developing an automated benchtop blood testing platform that delivers lab-accurate results from a few drops of blood in under 30 minutes — without requiring trained laboratory personnel. The company's flagship product, TruVerus, combines multiple blood test modalities into a single compact analyzer designed for point-of-care settings such as physician offices, clinics, urgent care centers, and long-term care facilities that lack on-site labs.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.